Профилактика тромботических осложнений в реконструктивной сосудистой хирургии с использованием низкомолекулярных гепаринов

Профилактика тромботических осложнений в реконструктивной сосудистой хирургии с использованием низкомолекулярных гепаринов

Автор: Гонтаренко В.Н., Сапелкин С.В., Титова М.И., Марынич А.А.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Статья в выпуске: 2 т.3, 2008 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140187662

IDR: 140187662

Список литературы Профилактика тромботических осложнений в реконструктивной сосудистой хирургии с использованием низкомолекулярных гепаринов

  • Bishop G, Pratschner T, Kail M, Mittlbock M, Turkof E, Puig S, Polterauer P, Kretschmer G. Anticoagulants, antiaggregants or nothing following carotid endarterectomy? Eur J Vasc Surg 1993 Jul; 7(4): 364-9.
  • Swedenborg J, Nydahl S, Egberg N. Related Articles, Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery. Eur J Vasc Endovasc Surg. 1996 Jan; 11(1): 59-64.
  • Samama CM, Thiry D, Elalamy I, Diaby M, Guillosson JJ, Kieffer E, Coriat P. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology. 2001 Jan; 94(1): 74-8.
  • McLean J. The thromboplastic action of cephalin. Am. J. Physiol. 41: 250, 1916.
  • McLean J. The discovery of heparin. Circulation 19: 75, 1959.
  • Howell WH, and Holt E. Two new factors in blood coagulation-heparin and pro-antithrombin. Am. J. Physiol. 47: 328, 1918.
  • Murray G. Heparin in surgical treatment of blood vessels. Arch Surg 1940; 40: 307.
  • Lane DA, MacGregor IR, Michalsky R, Kakkar VV. Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res 1978; 12: 257-271.
  • Anderson L-O, Barrowcliffe TW, Holmer E, Johnson EA, Sims GEC. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antihtrombin III and by gel filtration. Thromb Res 1976; 9: 575-583.
  • Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook G, Thomas DP. Anticoagulant activities of high and low molecular weight heparin fraction. Br J Haematol 1979; 41: 573-583.].
  • Holmer E, Kurachi K, Soderstrom G. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J 1981; 193: 395-400.
  • Kakkar VV, Murray WJ. Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative venous thromboembolism: a cooperative study. Br J Surg 1985; 72: 786-91.
  • Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ. 1991 Sep 7; 303(6802): 543-8.
  • Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ. 1992 Oct 17; 305(6859): 913-20.
  • Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997; 337(7): 447-52.
  • SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004 Jul 7; 292(1): 45-54.
  • Мелкумян А.Л. Патогенетическое обоснование использования фраксипарина в реконструктивной сосудистой хирургии: дисс. … канд. мед. наук. М., 2000: 126 с.
  • Melissari E, Stringer MD, Kakkar VV. The effect of a bolus injection of unfractionated or low molecular weight heparin during aortobifemoral bypass grafting. Eur J Vasc Surg. 1989 Apr; 3(2): 121-6.
  • Kroneman H, Eikelboom BC, Knot EA, de Smit P, Groenland TH, de Maat MP, Van Urk H. Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting. J Vasc Surg 1991 Aug; 14(2): 208-14.
  • Wilson NV, Melissari E, Standfield NJ, Kakkar VV. Intra-operative antithrombotic therapy with low molecular weight heparin in aortic surgery: How should heparin be administered? Eur J Vasc Surg. 1991; 5: 565-569.
  • Samama CM, Gigou F, Ill P. Low-molecular-weight heparin vs. unfractionated heparin in femorodistal reconstructive surgery: a multicenter open randomized study. Enoxart Study Group. Ann Vasc Surg. 1995; 9 Suppl: 45-53.
  • Gottlieb A, Tabares AH, Levy P, Sprung J, Kottke-Marchant K, Schoenwald PK. Use of Low Molecular Weight Heparin in Patients with Heparin-induced Thrombocytopenia Undergoing Carotid Endarterectomy. Anesthesiology 1996 Sep; 85(3): 678-81.
  • Norgren L; Swedish EnoxaVasc Study Group. Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial. J Vasc Surg. 2004 May; 39(5): 977-84.
  • Samama CM, Mouren S, Bridel MP, Combe S, Koskas F, Kieffer E, Viars P. Peri-and postoperative use of low molecular weight heparin in peripheral vascular surgery. Ann Fr Anesth Reanim. 1990; 9(2): 102-5. French.
  • Samama CM, Barre E, Combe S, Dreux S, Kieffer E, Viars P. A pilot study on the use of a low molecular weight heparin (Enoxaparin) in arterial reconstructive surgery. Semin Thromb Hemost. 1991 Oct; 17(4): 367-70.
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp